Zurich Cantonal Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $937K | Buy |
55,231
+801
| +1% | +$12.8K | ﹤0.01% | 1588 |
|
|
2026
Q1 | $807K | Buy |
+54,430
| New | +$796K | ﹤0.01% | 1560 |
|
|
2025
Q4 | – | Sell |
-42,094
| Closed | -$597K | – | 2643 |
|
|
2025
Q3 | $465K | Sell |
42,094
-402
| -0.9% | -$4.39K | ﹤0.01% | 1777 |
|
|
2025
Q2 | $360K | Sell |
42,496
-145
| -0.3% | -$1.16K | ﹤0.01% | 1858 |
|
|
2025
Q1 | $343K | Buy |
42,641
+8,390
| +24% | +$68K | ﹤0.01% | 1821 |
|
|
2024
Q4 | $308K | Buy |
34,251
+5,617
| +20% | +$45.8K | ﹤0.01% | 1929 |
|
|
2024
Q3 | $210K | Hold |
28,634
| – | – | ﹤0.01% | 2081 |
|
|
2024
Q2 | $164K | Hold |
28,634
| – | – | ﹤0.01% | 2139 |
|
|
2024
Q1 | $143K | Hold |
28,634
| – | – | ﹤0.01% | 2225 |
|
|
2023
Q4 | $257K | Buy |
28,634
+2,390
| +9% | +$19.7K | ﹤0.01% | 1936 |
|
|
2023
Q3 | $204K | Buy |
26,244
+6,513
| +33% | +$63.7K | ﹤0.01% | 1966 |
|
|
2023
Q2 | $191K | Buy |
19,731
+4,564
| +30% | +$47.4K | ﹤0.01% | 1955 |
|
|
2023
Q1 | $166K | Sell |
15,167
-1,252
| -8% | -$11K | ﹤0.01% | 1995 |
|
|
2022
Q4 | $70.9K | Hold |
16,419
| – | – | ﹤0.01% | 2476 |
|
|
2022
Q3 | $123K | Hold |
16,419
| – | – | ﹤0.01% | 2059 |
|
|
2022
Q2 | $165K | Sell |
16,419
-123
| -0.7% | -$1.38K | ﹤0.01% | 1910 |
|
|
2022
Q1 | $205K | Buy |
16,542
+1,375
| +9% | +$21.3K | ﹤0.01% | 1865 |
|
|
2021
Q4 | $347K | Buy |
15,167
+2,804
| +23% | +$66.4K | ﹤0.01% | 1713 |
|
|
2021
Q3 | $274K | Hold |
12,363
| – | – | ﹤0.01% | 1708 |
|
|
2021
Q2 | $162K | Hold |
12,363
| – | – | ﹤0.01% | 1946 |
|
|
2021
Q1 | $161K | Hold |
12,363
| – | – | ﹤0.01% | 1902 |
|
|
2020
Q4 | $170K | Hold |
12,363
| – | – | ﹤0.01% | 1944 |
|
|
2020
Q3 | $182K | Buy |
12,363
+4,953
| +67% | +$71.8K | ﹤0.01% | 1668 |
|
|
2020
Q2 | $121K | Buy |
7,410
+1,306
| +21% | +$20.9K | ﹤0.01% | 1841 |
|
|
2020
Q1 | $88K | Hold |
6,104
| – | – | ﹤0.01% | 1672 |
|
|
2019
Q4 | $124K | Hold |
6,104
| – | – | ﹤0.01% | 1589 |
|
|
2019
Q3 | $33K | Hold |
6,104
| – | – | ﹤0.01% | 2263 |
|
|
2019
Q2 | $40K | Hold |
6,104
| – | – | ﹤0.01% | 2193 |
|
|
2019
Q1 | $40K | Hold |
6,104
| – | – | ﹤0.01% | 2127 |
|
|
2018
Q4 | $41K | Buy |
6,104
+3,828
| +168% | +$22.1K | ﹤0.01% | 2143 |
|
|
2018
Q3 | $15K | Buy |
2,276
+1,578
| +226% | +$8.85K | ﹤0.01% | 2514 |
|
|
2018
Q2 | $4K | Buy |
+698
| New | +$3.89K | ﹤0.01% | 2521 |
|
Other funds holding AUPH
TCM
NMC
Zurich Cantonal Bank's AUPH Position: Q2 2026 in Review
Zurich Cantonal Bank increased its Aurinia Pharmaceuticals (AUPH) stake by 1.5% in Q2 2026, buying an estimated $12.8K and bringing the position to 55,231 shares worth $937K. The position accounts for ﹤0.01% of the portfolio, ranked #1588.
Zurich Cantonal Bank first reported a position in AUPH in Q2 2018 and has held it in 32 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.
- Zurich Cantonal Bank held 55,231 shares of Aurinia Pharmaceuticals worth $937K as of Q2 2026.
- Zurich Cantonal Bank bought 801 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $12.8K.
- Aurinia Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1588 holding.
- Zurich Cantonal Bank first reported a position in Aurinia Pharmaceuticals in Q2 2018 and has held it in 32 quarters since.
- 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.